Given the growth inhibitory function of Dok-1/2 (12, 17, 23), these findings suggest that the loss of Dok-1/2 enhances tumor cell growth in a tumor cell–intrinsic manner, while Dok-3 may induce malignant conversion of benign tumors in a tumor cell–extrinsic manner. Here, DOK3 is linked to benign neoplasm.